M1395 HCPCS Level II Code: Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group
Medicare Coverage & Payment
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Service not separately priced (pricing indicator 00)
- BETOS: Z2
- Effective: January 1, 2025
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Official Registry Overview & Definition
Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group is a HCPCS Level II code (M1395) for a Medicare-covered supply, service, or procedure. Short description: Init chemo w/def dur ec grp.
Nearest Codes in This Family
Official HCPCS Level II classifications closest to M1395 in its code family, with their registry titles.
- M1388 — Patients with documentation of an exam performed for recurrence of melanoma
- M1390 — Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period
- M1391 — All patients who were diagnosed with recurrent melanoma during the current performance period
- M1392 — Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)
- M1393 — Patients who were not diagnosed with recurrent melanoma during the current performance period
- M1394 — Stages i-iii breast cancer
- M1396 — Patients on a therapeutic clinical trial
- M1397 — Patients with recurrence/disease progression
- M1398 — Patients with baseline and follow-up promis surveys documented in the medical record
- M1399 — Patients who leave the practice during the follow-up period